UCLA researchers from the Department of Neurology have identified novel biomarkers of Sanfilippo Syndrome, leading to potential minimally invasive methods to detect Sanfilippo Syndrome and assess clinical trial outcomes.
More information to follow. Contact UCLA Technology Development Group if you would like to learn more in the meantime.